BioTech Medics, Inc., (PINKSHEETS: BMCS), a 10-year-old Pain Management Company, announced today the status of several positive aspects of the Company regarding revenues, assets and expansion.

Keith Houser, CEO of BioTech, stated: "In 2004 our company had little in income and less than $500,000 in assets. In four years BioTech has expanded to four owned and/or affiliated Pain Management & Wellness Centers, with nearly $7.6 million in assets including 4 US Patents and a 4 year combined aggregate income of nearly $6.5 million."

BioTech is poised to be a part of the $126 Billion Pain Management industry. Our goal is to have 100 or more BioTech L3aser(TM) Centers operating nationwide, similar to the 80 Lasik-Plus Eye Vision Centers operating. BioTech has finalized a strategic franchise alliance that will put BioTech on fast-track.

By offering franchises BioTech will receive a franchise fee, revenue from 1) the sale of medical lasers; 2) training of staff fees; 3) monthly protocol/ royalty fees; and 4) sales from SHBAN(TM) / BioBody(TM) products based on the gross income of each BioTech L3aser Center. Franchise Registration with each state regulatory agency will be required. The company is negotiating with a law firm specializing in franchises.

BioTech Medics has developed proprietary pain management protocols utilizing patented FDA 510(k) cleared high powered deep penetrating medical therapeutic lasers for reducing or eliminating muscular, skeletal, nerve and/or arthritic pain over the entire body. The procedures are drug-free, quick (15 to 30 minutes) safe and non-invasive. BioTech has affiliated centers operating in Dallas, Kansas City (Overland Park), Albuquerque and Santa Fe, NM. A new center is pending in Newport Beach.

BioTech's advantage over competition is their proprietary protocols for the high-powered therapeutic medical lasers that the patient feels healing their body. Most competitors use "cold lasers" that operate with 5,000 to 12,000 times less power. Patients cannot feel a cold laser. Back pain, carpal tunnel, shoulder, knees and hip pain are treated in each center.

Safe Harbor for Forward-Looking Statements.

This release contains forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995 (the "Act"). Such statements are subject to certain risks and uncertainties and actual results could differ materially from those expressed in any of the forward-looking statements. This is not an offer to buy or sell any security or franchise.

Contact: Investor Relations 972-274-5533

BioTech Medics (PK) (USOTC:BMCS)
Historical Stock Chart
From Mar 2025 to Apr 2025 Click Here for more BioTech Medics (PK) Charts.
BioTech Medics (PK) (USOTC:BMCS)
Historical Stock Chart
From Apr 2024 to Apr 2025 Click Here for more BioTech Medics (PK) Charts.